Abstract:Purpose: Nerve allografts are highly antigenic and, thus, require the continuous use of immunosuppressive drugs. FK 506 was found to pre-vent rejection successfully. However, clinically neurotoxic complications have been noted in the central and peripheral nervous system although an increased rate of axonal regeneration has also been shown after nerve crush experiments. To investigate whether a possible regeneration pro-moting potency of FK 506 is determined via an influence on Schwann cells, Schwann cells were cultured from the sciatic nerve of the rat. Methods: The effect of 100 μM FK 506 administered daily on these cultures was assessed microscopically over a period of seven days and compared to an untreated control group of cultures. Additionally, the changes in intracellular calcium were recorded using a laser scanning microscope. In vivo regeneration of autologous rat sciatic nerve grafts was assessed clinically, histologically and morphometrically after two and six weeks. The animals received a daily administration of 0.6 mg FK 506/kg body weight, the control received saline. Results: In vitro FK 506 increased the Schwann cell number in culture significantly compared to non treated cultures, while the fibrocyte population was decreased. FK 506 caused a transient increase of intracellular calcium levels in cultured cells. In vivo, a significantly higher axon count was observed in the FK 506 treated grafts after two weeks regeneration compared with controls. Good regeneration was noted in all grafts after six weeks regeneration. Conclusions: The increased axon counts and decreased myelin debris in the FK 506 grafts after two weeks indicate an accelerated Wallerian degeneration and increased axon sprouting into the graft initially. The inhibition of calcineurin activity is not the mediator of the neurotrophic effect. FK 506 promotes axonal regeneration through binding to FKBP-12. The increase of intracellular calcium may induce Schwann cell pro-liferation via calmodulin. The therapeutic relevance for autologous nerve grafting, however, has to be defined in further studies.

Rapamycin Promotes Schwann Cell Migration and Nerve Growth Factor Secretion.

Effects of rapamycin on number and activity of endothelial progenitor cells

Stimulation of Schwann cell proliferation and axonal regeneration by FK 506

FK506 contributes to peripheral nerve regeneration by inhibiting neuroinflammatory responses and promoting neuron survival

Changes of Ultrastructure of Regenerative Nerve Fibers in Response to Application of Sustained Releasing Agent FK506

Rapamycin Promotes Autophagy and Reduces Neural Tissue Damage and Locomotor Impairment after Spinal Cord Injury in Mice.

Evaluation of PRGD/FK506/NGF Conduits for Peripheral Nerve Regeneration in Rats

Effect Of combining FK506 and neurotrophins on neurite branching and elongation

Neuroprotective Effect of Rapamycin on Spinal Cord Injury Via Activation of the Wnt/β-catenin Signaling Pathway.

Rapamycin Preserves Neural Tissue, Promotes Schwann Cell Myelination and Reduces Glial Scar Formation After Hemi-Contusion Spinal Cord Injury in Mice

The Effects of Rapamycin on Endothelial Cell Migration and Vascular Endothelial Growth Factor Expression

The Neurotrophic Effects and Mechanism of Action for FK1706 in Neurorrhaphy Rat Models and SH-SY5Y Cells

Promotion of Nerve Regeneration in Peripheral Nerve by Short-Course FK506 after End-to-side Neurorrhaphy.

Influence of FK506 Upon Migration of Human Fetal Schwann Cells in Vitro

Acceleration of peripheral nerve regeneration following FK506 administration

Tacrolimus and Nerve Growth factor Treated Allografts for Neural Tissue Regeneration.

Inhibitory Effect of Rapamycin on Connective Tissue Growth Factor-Stimulated Cell Proliferation and Fibronectin Secretion in Myofibroblasts

Local FK506 dose‐dependent study using a novel three‐dimensional organotypic assay

An integrated microfluidic device for screening the effective concentration of locally applied tacrolimus for peripheral nerve regeneration

Sequential expression of miR-221-3p and miR-338-3p in Schwann cells as a therapeutic strategy to promote nerve regeneration and functional recovery

Rapamycin and FK506 Derivative TH2849 Could Ameliorate Neurodegenerative Diseases Through Autophagy with Low Immunosuppressive Effect